Neisseria gonorrhoeae isolates resistant to extended spectrum cephalosporins and macrolides isolated from symptomatic men in western Kenya
International Journal of STD & AIDS · 2024
DOI: 10.1177/09564624241273774 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of STD & AIDS, 2024. Verfasst von Walter Agingu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Nyanza Reproductive Health Society, Kisumu, Kenya. Hauptthemen laut MEDLINE: Neisseria gonorrhoeae, Gonorrhea, Anti-Bacterial Agents, Microbial Sensitivity Tests. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 42 Literaturangaben. Gefördert von: The Henry M. Jackson Foundation.
Abstract (Originalsprache)
Background
We characterized the antimicrobial resistance (AMR) profiles of Neisseria gonorrhoeae (NG) isolated from symptomatic men at a sexually transmitted infection clinic in Kisumu, Kenya.
Methods
Two urethral swabs were obtained from symptomatic men between 2020 and 2022, one for Gram’s stain and the other inoculated directly onto modified Thayer-Martin media containing 1% VCNT and 1% IsoVitaleX enrichment. Culture results were confirmed by colony morphology, Gram’s stain and oxidase test. Duplicate isolates were shipped to Uniformed Services University for confirmation and characterization. Susceptibility to eight drugs was assessed by E-test. Agar dilution confirmed resistance to ceftriaxone, cefixime, and azithromycin. Susceptibility, intermediate resistance (IR), and resistance (R) were determined according to published criteria.
Results
Of 154 enrolled participants, 112 were culture-positive for NG. Agar dilution results in 110 (98.2%) showed the following: azithromycin-R (1.8%), and 4.5% R or IR to ceftriaxone or cefixime: ceftriaxone-R (0.9%), ceftriaxone-IR (2.7%), and cefixime-IR (2.7%). By E-test, most isolates were IR or R to tetracycline (97.2%), penicillin (90.9%), and ciprofloxacin (95.4%).
Conclusions
We detected NG with resistance to azithromycin and ceftriaxone, indicating a growing threat to the current Kenyan dual syndromic treatment of urethritis with cephalosporin plus macrolides. Ongoing AMR surveillance is essential for effective drug choices.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Nyanza Reproductive Health Society, Kisumu, Kenya.
- Department of Microbiology & Immunology, Uniformed Services University of the Health Sciences, Bethesda, MD, USA.
- The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., Bethesda, MD, USA.
- Department of Preventive Medicine & Biostatistics, Uniformed Services University, Bethesda, MD, USA.
- University of Illinois Chicago, Chicago, IL, USA.
ORCID-Profile: Supriya D Mehta
Förderung
- The Henry M. Jackson Foundation
Zitieren
APA
Agingu, W., Otieno, F., Dibondo, E., Wambua, P., Le Van, A., Jerse, A., Garges, E., & Mehta, S. D. (2024). Neisseria gonorrhoeae isolates resistant to extended spectrum cephalosporins and macrolides isolated from symptomatic men in western Kenya. International Journal of STD & AIDS. https://doi.org/10.1177/09564624241273774
Vancouver
Agingu W, Otieno F, Dibondo E, Wambua P, Le Van A, Jerse A, et al. Neisseria gonorrhoeae isolates resistant to extended spectrum cephalosporins and macrolides isolated from symptomatic men in western Kenya. International Journal of STD & AIDS. 2024. doi:10.1177/09564624241273774
BibTeX
@article{Agingu2024,
author = {Agingu, Walter and Otieno, Fredrick and Dibondo, Ezekiel and Wambua, Patriciah and Le Van, Adriana and Jerse, Ann and Garges, Eric and Mehta, Supriya D},
title = {Neisseria gonorrhoeae isolates resistant to extended spectrum cephalosporins and macrolides isolated from symptomatic men in western Kenya},
journal = {International Journal of STD & AIDS},
year = {2024},
doi = {10.1177/09564624241273774}
}
EUVIMED